{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:38:53Z","timestamp":1775792333773,"version":"3.50.1"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T00:00:00Z","timestamp":1447027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12017-015-8376-4","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T08:29:04Z","timestamp":1447057744000},"page":"37-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Genetic Factors Affecting Late-Onset Alzheimer\u2019s Disease Susceptibility"],"prefix":"10.1007","volume":"18","author":[{"given":"Maryam","family":"Rezazadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Khorrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarlan","family":"Yeghaneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnaz","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Jalal","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaser","family":"Heshmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalal","family":"Gharesouran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"8376_CR1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1755-8794-1-44","volume":"1","author":"R Abraham","year":"2008","unstructured":"Abraham, R., Moskvina, V., Sims, R., Hollingworth, P., Morgan, A., Georgieva, L., et al. (2008). A genome-wide association study for late-onset Alzheimer\u2019s disease using DNA pooling. BMC Medical Genomics, 1, 44.","journal-title":"BMC Medical Genomics"},{"key":"8376_CR200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s100720070075","volume":"21","author":"M Alberoni","year":"2000","unstructured":"Alberoni, M., Alfieri, P., Vesuviana, S., Amici, S., Antana, D., Appollonio, R. I., et al. (2000). The Dementia Study Group of the Italian Neurological Society. Guidelines for the diagnosis of dementia and Alzheimer\u2019s disease. Neurological Sciences, 21, 187\u2013194.","journal-title":"Neurological Sciences"},{"issue":"5","key":"8376_CR2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.10515","volume":"114","author":"V Alvarez","year":"2002","unstructured":"Alvarez, V., Mata, I. F., Gonzalez, P., Lahoz, C. H., Mart\u00ednez, C., Pe\u00f1a, J., et al. (2002). Association between the TNFalpha-308 A\/G polymorphism and the onset-age of Alzheimer disease. American Journal of Medical Genetics, 114(5), 574\u2013577.","journal-title":"American Journal of Medical Genetics"},{"key":"8376_CR401","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychological Association.","edition":"4"},{"issue":"6","key":"8376_CR3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-013-1111-z","volume":"125","author":"K Ando","year":"2013","unstructured":"Ando, K., Brion, J., Stygelbout, V., Suain, V., Authelet, M., Dedecker, R., et al. (2013). Clathrin adaptor CALM\/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer\u2019s brains. Acta Neuropathologica, 125(6), 861\u2013878.","journal-title":"Acta Neuropathologica"},{"issue":"3","key":"8376_CR4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/gm34","volume":"1","author":"D Avramopoulos","year":"2009","unstructured":"Avramopoulos, D. (2009). Genetics of Alzheimer\u2019s disease: Recent advances. Genome Medicine, 1(3), 34.","journal-title":"Genome Medicine"},{"issue":"6","key":"8376_CR5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.neuint.2003.08.004","volume":"44","author":"F Ba","year":"2004","unstructured":"Ba, F., Pang, P. K., Davidge, S. T., & Benishin, C. G. (2004). The neuroprotective effects of estrogen in SK-N-SH neuroblastoma cell cultures. Neurochemistry International, 44(6), 401\u2013411.","journal-title":"Neurochemistry International"},{"key":"8376_CR800","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1196\/annals.1386.012","volume":"1089","author":"CR Balistreri","year":"2006","unstructured":"Balistreri, C. R., Grimaldi, M. P., Vasto, S., Listi, F., Chiappelli, M., Licastro, F., et al. (2006). Association between the polymorphism of CCR5 and Alzheimer\u2019s disease: Results of a study performed on male and female patients from Northern Italy. Annals of the New York Academy of Sciences, 1089, 454\u2013461.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"13","key":"8376_CR6","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/hmg\/9.13.2043","volume":"9","author":"L Becherini","year":"2000","unstructured":"Becherini, L., Gennari, L., Masi, L., Mansani, R., Massart, F., Morelli, A., et al. (2000). Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Human Molecular Genetics, 9(13), 2043\u20132050.","journal-title":"Human Molecular Genetics"},{"issue":"9","key":"8376_CR7","doi-asserted-by":"crossref","first-page":"e1004606","DOI":"10.1371\/journal.pgen.1004606","volume":"10","author":"GW Beecham","year":"2014","unstructured":"Beecham, G. W., Hamilton, K., Naj, A. C., Martin, E. R., Huentelman, M., Myers, A. J., et al. (2014). Genome-wide association meta-analysis of neuropathologic features of Alzheimer\u2019s disease and related dementias. PLoS Genetics, 10(9), e1004606.","journal-title":"PLoS Genetics"},{"issue":"1","key":"8376_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajhg.2008.12.008","volume":"84","author":"GW Beecham","year":"2009","unstructured":"Beecham, G. W., Martin, E. R., Li, Y. J., Slifer, M. A., Gilbert, J. R., Haines, J. L., et al. (2009). Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. American Journal of Human Genetics, 84(1), 35\u201343.","journal-title":"American Journal of Human Genetics"},{"issue":"6","key":"8376_CR9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cell.2008.11.030","volume":"135","author":"L Bertram","year":"2008","unstructured":"Bertram, L., Schjeide, B. M., Hooli, B., Mullin, K., Hiltunen, M., Soininen, H., et al. (2008). No association between CALHM1 and Alzheimer\u2019s disease risk. Cell, 135(6), 993\u2013994. (author reply 994\u2013996).","journal-title":"Cell"},{"key":"8376_CR10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","volume":"107","author":"L Bertram","year":"2012","unstructured":"Bertram, L., & Tanzi, R. E. (2012). The genetics of Alzheimer\u2019s disease. Progress in Molecular Biology and Translational Science, 107, 79\u2013100.","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"2","key":"8376_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2217\/nmt.11.11","volume":"1","author":"MC Biagioni","year":"2011","unstructured":"Biagioni, M. C., & Galvin, J. E. (2011). Using biomarkers to improve detection of Alzheimer\u2019s disease. Neurodegenerative Disease Management, 1(2), 127\u2013139.","journal-title":"Neurodegenerative Disease Management"},{"issue":"6","key":"8376_CR12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archneurol.2010.108","volume":"67","author":"A Biffi","year":"2010","unstructured":"Biffi, A., Anderson, C. D., Desikan, R. S., Sabuncu, M., Cortellini, L., Schmansky, N., et al. (2010). Genetic variation and neuroimaging measures in Alzheimer disease. Archives of Neurology, 67(6), 677\u2013685.","journal-title":"Archives of Neurology"},{"issue":"4","key":"8376_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/GIM.0b013e31816b64dc","volume":"10","author":"TD Bird","year":"2008","unstructured":"Bird, T. D. (2008). Genetic aspects of Alzheimer disease. Genetics in Medicine, 10(4), 231\u2013239.","journal-title":"Genetics in Medicine"},{"issue":"1","key":"8376_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/hmg\/ddg007","volume":"2","author":"D Blacker","year":"2003","unstructured":"Blacker, D., Bertram, L., Saunders, A. J., Moscarillo, T. J., Albert, M. S., Wiener, H., et al. (2003). Genetics Initiative Alzheimer\u2019s Disease Study Group: Results of a high-resolution genome screen of 437 Alzheimer\u2019s disease families. Human Molecular Genetics, 2(1), 23\u201332.","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"8376_CR15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","volume":"48","author":"D Blacker","year":"1997","unstructured":"Blacker, D., Haines, J. L., Rodes, L., Terwedow, H., Go, R. C., Harrell, L. E., et al. (1997). ApoE-4 and age at onset of Alzheimer\u2019s disease: The NIMH genetics initiative. Neurology, 48(1), 139\u2013147.","journal-title":"Neurology"},{"issue":"1\u20132","key":"8376_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00439-005-0078-9","volume":"119","author":"ME Blomqvist","year":"2006","unstructured":"Blomqvist, M. E., Reynolds, C., Katzov, H., Feuk, L., Andreasen, N., Bogdanovic, N., et al. (2006). Towards compendia of negative genetic association studies: An example for Alzheimer disease. Human Genetics, 119(1\u20132), 29\u201337.","journal-title":"Human Genetics"},{"issue":"1","key":"8376_CR2001","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2010-1357","volume":"20","author":"M Boada","year":"2010","unstructured":"Boada, M., Ant\u00fanez, C., L\u00f3pez-Arrieta, J., Gal\u00e1n, J. J., Mor\u00f3n, F. J., Hern\u00e1ndez, I., et al. (2010). CALHM1 P86L polymorphism is associated with late-onset Alzheimer\u2019s disease in a recessive model. Journal of Alzheimer\u2019s Disease, 20(1), 247\u2013251.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"2","key":"8376_CR17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/bbrc.1999.1665","volume":"265","author":"ML Brandi","year":"1999","unstructured":"Brandi, M. L., Becherini, L., Gennari, L., Racchi, M., Bianchetti, A., Nacmias, B., et al. (1999). Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer\u2019s disease. Biochemical and Biophysical Research Communications, 265(2), 335\u2013338.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"11","key":"8376_CR18","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jnen\/61.11.1013","volume":"61","author":"M Bsibsi","year":"2002","unstructured":"Bsibsi, M., Ravid, R., Gveric, D., & Noort, J. M. (2002). Broad expression of Toll like receptors in the human central nervous system. Journal of Neuropathology and Experimental Neurology, 61(11), 1013\u20131021.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"8376_CR19","first-page":"1","volume":"27","author":"R Cacabelos","year":"2005","unstructured":"Cacabelos, R., Fernandez-Novoa, L., Lombardi, V., Kubota, Y., & Takeda, M. (2005). Molecular genetics of Alzheimer\u2019s disease and aging. Methods and Findings in Experimental and Clinical Pharmacology, 27, 1\u2013573.","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"issue":"8","key":"8376_CR20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archneurol.2010.147","volume":"67","author":"MM Carrasquillo","year":"2010","unstructured":"Carrasquillo, M. M., Belbin, O., Hunter, T. A., Ma, L., Bisceglio, G. D., Zou, F., et al. (2010). Replication of CLU, CR1, and PICALM associations with alzheimer disease. Archives of Neurology, 67(8), 961\u2013964.","journal-title":"Archives of Neurology"},{"issue":"1","key":"8376_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/ENDO:21:1:27","volume":"21","author":"C Chiueh","year":"2003","unstructured":"Chiueh, C., Lee, S., Andoh, T., & Murphy, D. (2003). Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen. Endocrine, 21(1), 27\u201331.","journal-title":"Endocrine"},{"issue":"6","key":"8376_CR260","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/1096-8628(20001204)96:6<823::AID-AJMG26>3.0.CO;2-I","volume":"96","author":"JS Collins","year":"2000","unstructured":"Collins, J. S., Perry, R. T., Watson, B., Harrell, L. E., Acton, R. T., Blacker, D., et al. (2000). Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: The NIMH Alzheimer Disease Genetics Initiative. American Journal of Medical Genetics, 96(6), 823\u2013830.","journal-title":"American Journal of Medical Genetics"},{"issue":"3","key":"8376_CR270","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neulet.2004.05.058","volume":"366","author":"O Combarros","year":"2004","unstructured":"Combarros, O., Infante, J., Llorca, J., Pe\u00f1a, N., Fern\u00e1ndez-Viadero, C., & Berciano, J. (2004). The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer\u2019s disease. Neuroscience Letters, 366(3), 312\u2013314.","journal-title":"Neuroscience Letters"},{"issue":"9","key":"8376_CR22","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00415-006-0502-7","volume":"254","author":"O Combarros","year":"2007","unstructured":"Combarros, O., Riancho, J. A., Arozamena, J., Mateo, I., Llorca, J., Infante, J., et al. (2007). Interaction between estrogen receptor-alpha and butyrylcholinesterase genes modulates Alzheimer\u2019s disease risk. Journal of Neurology, 254(9), 1290\u20131292.","journal-title":"Journal of Neurology"},{"issue":"4","key":"8376_CR23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4088\/JCP.v68n0419","volume":"68","author":"KD Coon","year":"2007","unstructured":"Coon, K. D., Myers, A. J., Craig, D. W., Webster, J. A., Pearson, J. V., Lince, D. H., et al. (2007). A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer\u2019s disease. Journal of Clinical Psychiatry, 68(4), 613\u2013618.","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"8376_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000093315","volume":"22","author":"RM Corbo","year":"2006","unstructured":"Corbo, R. M., Gambina, G., Ruggeri, M., & Scacchi, R. (2006). Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer\u2019s disease and their effect on apolipoprotein E concentrations. Dementia and Geriatric Cognitive Disorders, 22(1), 67\u201372.","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"2","key":"8376_CR25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7(2), 180\u2013184.","journal-title":"Nature Genetics"},{"issue":"16","key":"8376_CR26","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1093\/hmg\/ddq221","volume":"19","author":"J Corneveaux","year":"2010","unstructured":"Corneveaux, J., Myers, A. J., Allen, A. N., Pruzin, J., Ramirez, M., Engel, A., et al. (2010). Association of CR1, CLU and PICALM with Alzheimer\u2019s disease in a cohort of clinically characterized and neuropathologically verified individuals. Human Molecular Genetics, 19(16), 3295\u20133301.","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"8376_CR330","first-page":"31","volume":"19","author":"PJ Cui","year":"2009","unstructured":"Cui, P. J., Zheng, L., Cao, L., Wang, Y., Deng, Y. L., Wang, G., et al. (2009). CALHM1 P86L polymorphism is a risk factor for Alzheimer\u2019s disease in the Chinese population. Journal of Alzheimer\u2019s Disease, 19(1), 31\u201335.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"1","key":"8376_CR340","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(03)00854-1","volume":"350","author":"D Culpan","year":"2003","unstructured":"Culpan, D., MacGowan, S. H., Ford, J. M., Nicoll, J. A., Griffin, W. S., Dewar, D., et al. (2003). Tumour necrosis factor-alpha gene polymorphisms and Alzheimer\u2019s disease. Neuroscience Letters, 350(1), 61\u201365.","journal-title":"Neuroscience Letters"},{"key":"8376_CR27","doi-asserted-by":"crossref","first-page":"207178","DOI":"10.1155\/2013\/207178","volume":"2013","author":"PA Defina","year":"2013","unstructured":"Defina, P. A., Moser, S. O., Glenn, M., Lichtenstein, J. D., & Fellus, J. (2013). Alzheimer\u2019s disease clinical and research update for health care practitioners. Journal of Aging Research, 2013, 207178.","journal-title":"Journal of Aging Research"},{"issue":"7","key":"8376_CR28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2008.05.048","volume":"133","author":"U Dreses-Werringloer","year":"2008","unstructured":"Dreses-Werringloer, U., Lambert, J. C., Vingtdeux, V., Zhao, H., Vais, H., Siebert, A., et al. (2008). A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer\u2019s disease risk. Cell, 133(7), 1149\u20131161.","journal-title":"Cell"},{"issue":"3","key":"8376_CR29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ncl.2007.03.009","volume":"25","author":"N Ertekin-Taner","year":"2007","unstructured":"Ertekin-Taner, N. (2007). Genetics of Alzheimer\u2019s disease: A centennial review. Neurologic Clinics, 25(3), 611\u2013667.","journal-title":"Neurologic Clinics"},{"issue":"1","key":"8376_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/alzrt26","volume":"2","author":"N Ertekin-Taner","year":"2010","unstructured":"Ertekin-Taner, N. (2010). Genetics of Alzheimer disease in the pre- and post-GWAS era. Alzheimer\u2019s Research & Therapy, 2(1), 3.","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"5","key":"8376_CR31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.410380515","volume":"38","author":"LA Farrer","year":"1995","unstructured":"Farrer, L. A., Cupples, L. A., van Duijn, C. M., Kurz, A., Zimmer, R., et al. (1995). Apolipoprotein E genotype in patients with Alzheimer\u2019s disease: Implications for the risk of dementia among relatives. Annals of Neurology, 38(5), 797\u2013808.","journal-title":"Annals of Neurology"},{"issue":"1","key":"8376_CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2004.07.005","volume":"225","author":"D Galimberti","year":"2004","unstructured":"Galimberti, D., Fenoglio, C., Lovati, C., Gattia, A., Guidia, I., Venturellia, E., et al. (2004). CCR2-64I polymorphism and CCR5\u039432 deletion in patients with Alzheimer\u2019s disease. Journal of the Neurological Sciences, 225(1), 79\u201383.","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"8376_CR33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neurobiolaging.2004.04.004","volume":"26","author":"M Gatz","year":"2005","unstructured":"Gatz, M., Fratiglioni, L., Johansson, B., Berg, S., Mortimer, J. A., Reynolds, C. A., et al. (2005). Complete ascertainment of dementia in the Swedish Twin Registry: The HARMONY study. Neurobiology of Aging, 26(4), 439\u2013447.","journal-title":"Neurobiology of Aging"},{"issue":"6","key":"8376_CR34","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10519-010-9407-4","volume":"40","author":"M Gatz","year":"2010","unstructured":"Gatz, M., Reynolds, C. A., Finkel, D., Pedersen, N. L., & Walters, E. (2010). Dementia in Swedish twins: Predicting incident cases. Behavior Genetics, 40(6), 768\u2013775.","journal-title":"Behavior Genetics"},{"issue":"1","key":"8376_CR35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JAD-130497","volume":"37","author":"D Gezen-Ak","year":"2013","unstructured":"Gezen-Ak, D., Dursun, E., Hana\u011fas\u0131, H., Bilgi\u00e7, B., Lohman, E., Araz, \u00d6. S., et al. (2013). BDNF, TNF\u03b1, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer\u2019s disease or mild cognitive impairment. Journal of Alzheimer\u2019s Disease, 37(1), 185\u2013195.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"4","key":"8376_CR36","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s12031-014-0377-5","volume":"54","author":"J Gharesouran","year":"2014","unstructured":"Gharesouran, J., Rezazadeh, M., Khorrami, A., Ghojazadeh, M., Talebi, M., et al. (2014). Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer\u2019s disease and evaluation for interactions with APOE genotypes. Journal of Molecular Neuroscience, 54(4), 780\u2013786.","journal-title":"Journal of Molecular Neuroscience"},{"issue":"2","key":"8376_CR37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2298\/GENSR1302503G","volume":"45","author":"J Gharesouran","year":"2013","unstructured":"Gharesouran, J., Rezazadeh, M., & Mohaddes, S. M. (2013). Investigation of five polymorphic DNA markers associated with late onset Alzheimer disease. Genetika, 45(2), 503\u2013514.","journal-title":"Genetika"},{"issue":"1","key":"8376_CR460","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000191203","volume":"27","author":"V Giedraitis","year":"2009","unstructured":"Giedraitis, V., Kilander, L., Degerman-Gunnarsson, M., Sundel\u00f6f, J., Axelsson, T., Syv\u00e4nen, A. C., et al. (2009). Genetic analysis of Alzheimer\u2019s disease in the Uppsala Longitudinal Study of Adult Men. Dementia and Geriatric Cognitive Disorders, 27(1), 59\u201368.","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"6311","key":"8376_CR38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature, 349(6311), 704\u2013706.","journal-title":"Nature"},{"issue":"6","key":"8376_CR39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/GIM.0b013e31821d69b8","volume":"13","author":"JS Goldman","year":"2011","unstructured":"Goldman, J. S., Hahn, S. E., Catania, J. W., LaRusse-Eckert, S., Butson, M. B., Rumbaugh, M., et al. (2011). Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in Medicine, 13(6), 597\u2013605.","journal-title":"Genetics in Medicine"},{"issue":"2","key":"8376_CR40","first-page":"1","volume":"39","author":"E Gozalpour","year":"2010","unstructured":"Gozalpour, E., Kamali, K., Mohammd, K., Khorram Khorshid, H. R., Ohadi, M., Karimloo, M., et al. (2010). Association between Alzheimer\u2019s disease and apolipoprotein E polymorphisms. Iranian Journal of Public Health, 39(2), 1\u20136.","journal-title":"Iranian Journal of Public Health"},{"issue":"12","key":"8376_CR41","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","volume":"67","author":"J Gyungah","year":"2010","unstructured":"Gyungah, J., Adam, C. N., & Gary, W. B. (2010). Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of Neurology, 67(12), 1473\u20131484.","journal-title":"Archives of Neurology"},{"issue":"3","key":"8376_CR42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0854.2007.00694.x","volume":"9","author":"A Harel","year":"2008","unstructured":"Harel, A., Wu, F., Mattson, M. P., Morris, C. M., & Yao, P. J. (2008). Evidence for CALM in directing VAMP2 trafficking. Traffic, 9(3), 417\u2013429.","journal-title":"Traffic"},{"issue":"10","key":"8376_CR43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M., et al. (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease, and shows evidence for additional susceptibility genes. Nature Genetics, 41(10), 1088\u20131093.","journal-title":"Nature Genetics"},{"issue":"4","key":"8376_CR44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/rej.2011.1302","volume":"15","author":"LW Harries","year":"2012","unstructured":"Harries, L. W., Bradley-smith, R. M., Llewellyn, D. J., Pilling, L. C., Fellows, A., Henley, W., et al. (2012). Leukocyte CCR2 expression is associated with mini-mental state examination score in older adults. Rejuvenation Research, 15(4), 395\u2013404.","journal-title":"Rejuvenation Research"},{"issue":"8","key":"8376_CR45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","volume":"31","author":"DM Hatters","year":"2006","unstructured":"Hatters, D. M., Peters-Libeu, C. A., & Weisgraber, K. H. (2006). Apolipoprotein E structure: Insights into function. Trends in Biochemical Sciences, 31(8), 445\u2013454.","journal-title":"Trends in Biochemical Sciences"},{"issue":"5","key":"8376_CR46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J. C., Carrasquillo, M. M., et al. (2011). Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nature Genetics, 43(5), 429\u2013435.","journal-title":"Nature Genetics"},{"issue":"2","key":"8376_CR560","doi-asserted-by":"crossref","first-page":"e54483","DOI":"10.1371\/journal.pone.0054483","volume":"8","author":"CA Hostage","year":"2013","unstructured":"Hostage, C. A., Roy Choudhury, K., Doraiswamy, P. M., & Petrella, J. R. (2013). Dissecting the gene dose-effects of the APOE \u03b54 and \u03b52 alleles on hippocampal volumes in aging and Alzheimer\u2019s disease. PLoS ONE, 8(2), e54483.","journal-title":"PLoS ONE"},{"issue":"2","key":"8376_CR47","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0304-3940(94)90026-4","volume":"174","author":"H Houlden","year":"1994","unstructured":"Houlden, H., Crook, R., Hardy, J., Roques, P., Collinge, J., & Rossor, M. (1994). Confirmation that familial clustering and age of onset in late onset Alzheimer\u2019s disease are determined at the apolipoprotein E locus. Neuroscience Letters, 174(2), 222\u2013224.","journal-title":"Neuroscience Letters"},{"issue":"2","key":"8376_CR48","doi-asserted-by":"crossref","first-page":"e16616","DOI":"10.1371\/journal.pone.0016616","volume":"6","author":"X Hu","year":"2011","unstructured":"Hu, X., Pickering, E., Liu, Y. C., Hall, S., Fournier, H., Katz, E., et al. (2011). Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer\u2019s disease. PLoS One, 6(2), e16616.","journal-title":"PLoS One"},{"issue":"2\u20133","key":"8376_CR590","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neulet.2004.08.016","volume":"370","author":"C Huerta","year":"2004","unstructured":"Huerta, C., Alvarez, V., Mata, I. F., Coto, E., Ribacoba, R., Mart\u00ednez, C., et al. (2004). Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer\u2019s and Parkinson\u2019s disease. Neuroscience Letters, 370(2\u20133), 151\u2013154.","journal-title":"Neuroscience Letters"},{"issue":"2","key":"8376_CR600","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ajmg.b.31014","volume":"153B","author":"K Inoue","year":"2010","unstructured":"Inoue, K., Tanaka, N., Yamashita, F., Sawano, Y., Asada, T., & Goto, Y. (2010). The P86L common allele of CALHM1 does not influence risk for Alzheimer disease in Japanese cohorts. American Journal of Medical Genetics: Part B Neuropsychiatric Genetics, 153B(2), 532\u2013535.","journal-title":"American Journal of Medical Genetics: Part B Neuropsychiatric Genetics"},{"issue":"3","key":"8376_CR50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000017224","volume":"11","author":"Y Ji","year":"2000","unstructured":"Ji, Y., Urakami, K., Wada-Isoe, K., Adachi, Y., & Nakashima, K. (2000). Estrogen receptor gene polymorphisms in patients with Alzheimer\u2019s disease, vascular dementia and alcohol-associated dementia. Dementia and Geriatric Cognitive Disorders, 11(3), 119\u2013122.","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"11","key":"8376_CR51","doi-asserted-by":"crossref","first-page":"e13950","DOI":"10.1371\/journal.pone.0013950","volume":"5","author":"L Jones","year":"2010","unstructured":"Jones, L., Holmans, P. A., Hamshere, M. L., Harold, D., Moskvina, V., Ivanov, D., et al. (2010). Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer\u2019s disease. PLoS One, 5(11), e13950.","journal-title":"PLoS One"},{"issue":"12","key":"8376_CR52","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","volume":"67","author":"G Jun","year":"2010","unstructured":"Jun, G., Naj, A. C., Beecham, G. W., Wang, L. S., Buros, J., Gallins, P. J., et al. (2010). Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of Neurology, 67(12), 1473\u20131484.","journal-title":"Archives of Neurology"},{"issue":"3","key":"8376_CR53","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neurobiolaging.2010.04.015","volume":"33","author":"MI Kamboh","year":"2012","unstructured":"Kamboh, M. I., Minster, R. L., Demirci, F. Y., Ganguli, M., Dekosky, S. T., Lopez, O. L., et al. (2012). Association of CLU and PICALM variants with Alzheimer\u2019s disease. Neurobiology of Aging, 33(3), 518\u2013521.","journal-title":"Neurobiology of Aging"},{"issue":"11","key":"8376_CR54","doi-asserted-by":"crossref","first-page":"e50976","DOI":"10.1371\/journal.pone.0050976","volume":"7","author":"CM Karch","year":"2012","unstructured":"Karch, C. M., Jeng, A. T., Nowotny, P., Cady, J., Cruchaga, C., & Goate, A. M. (2012). Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains. PLoS One, 7(11), e50976.","journal-title":"PLoS One"},{"issue":"2","key":"8376_CR55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/alzrt71","volume":"3","author":"EH Kok","year":"2011","unstructured":"Kok, E. H., Luoto, T., Haikonen, S., Goebeler, S., Haapasalo, H., & Karhunen, P. J. (2011). CLU, CR1 and PICALM genes associate with Alzheimer\u2019s-related senile plaques. Alzheimer\u2019s Research & Therapy, 3(2), 12\u201315.","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"4","key":"8376_CR56","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1582-4934.2008.00557.x","volume":"13","author":"J Koren","year":"2009","unstructured":"Koren, J., Jinwal, U. K., Lee, D. C., Jones, J. R., Shults, C. L., Johnson, A. G., et al. (2009). Chaperone signalling complexes in Alzheimer\u2019s disease. Journal of Cellular and Molecular Medicine, 13(4), 619\u2013630.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"3","key":"8376_CR57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3940(01)01806-7","volume":"306","author":"JC Lambert","year":"2001","unstructured":"Lambert, J. C., Harris, J. M., Mann, D., Lemmon, H., Coates, J., Cumming, A., et al. (2001). Are the estrogen receptors involved in Alzheimer\u2019s disease? Neuroscience Letters, 306(3), 193\u2013197.","journal-title":"Neuroscience Letters"},{"issue":"10","key":"8376_CR58","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert, J. C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., et al. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nature Genetics, 41(10), 1094\u20131099.","journal-title":"Nature Genetics"},{"issue":"4","key":"8376_CR59","doi-asserted-by":"crossref","first-page":"756.e11-5","DOI":"10.1016\/j.neurobiolaging.2010.11.022","volume":"32","author":"JC Lambert","year":"2011","unstructured":"Lambert, J. C., Zelenika, D., Hiltunen, M., Chouraki, V., Combarros, O., Bullido, M. J., et al. (2011). Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiology of Aging, 32(4), 756.e11-5.","journal-title":"Neurobiology of Aging"},{"key":"8376_CR60","first-page":"137","volume":"336","author":"GE Landreth","year":"2009","unstructured":"Landreth, G. E., & Reed-Geaghan, E. G. (2009). TLRs in Alzheimer\u2019s disease. Current Topics in Microbiology and Immunology, 336, 137\u2013153.","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"8376_CR61","first-page":"320","volume":"3","author":"JH Lee","year":"2011","unstructured":"Lee, J. H., Cheng, R., Barral, S., Reitz, C., Medrano, M., Lantigua, R., et al. (2011). Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Archives of Neurology, 3, 320\u2013328.","journal-title":"Archives of Neurology"},{"issue":"6","key":"8376_CR62","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.410400604","volume":"40","author":"E Levy-Lahad","year":"1996","unstructured":"Levy-Lahad, E., & Bird, T. D. (1996). Genetic factors in Alzheimer\u2019s disease: A review of recent advances. Annals of Neurology., 40(6), 829\u2013840.","journal-title":"Annals of Neurology."},{"issue":"1","key":"8376_CR750","first-page":"45","volume":"65","author":"H Li","year":"2008","unstructured":"Li, H., Wetten, S., Li, L., St Jean, P. L., Upmanyu, R., Surh, L., et al. (2008). Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Archives of Neurology, 65(1), 45\u201353.","journal-title":"Archives of Neurology"},{"issue":"7","key":"8376_CR760","first-page":"651","volume":"24","author":"GF Lin","year":"2003","unstructured":"Lin, G. F., Ma, Q. W., Zhang, D. S., Zha, Y. L., Lou, K. J., & Shen, J. H. (2003). Polymorphism of alpha-estrogen receptor and aryl hydrocarbon receptor genes in dementia patients in Shanghai suburb. Acta Pharmacologica Sinica, 24(7), 651\u2013656.","journal-title":"Acta Pharmacologica Sinica"},{"issue":"2","key":"8376_CR63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C Liu","year":"2009","unstructured":"Liu, C., Kanekiyo, T., Xu, H., & Bu, G. (2009). Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nature Reviews Neurology, 9(2), 106\u2013118.","journal-title":"Nature Reviews Neurology"},{"issue":"5","key":"8376_CR64","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1017\/S1041610209990068","volume":"21","author":"SL Ma","year":"2009","unstructured":"Ma, S. L., Tang, N. L., Tam, C. W., Lui, V. W., Lau, E. S., Zhang, Y. P., et al. (2009). Polymorphisms of the estrogen receptor alpha (ESR1) gene and the risk of Alzheimer\u2019s disease in a southern Chinese community. International Psychogeriatrics, 21(5), 977\u2013986.","journal-title":"International Psychogeriatrics"},{"key":"8376_CR65","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0404.2006.00679.x","volume":"185","author":"RW Mahley","year":"2006","unstructured":"Mahley, R. W., & Huang, Y. (2006). Apolipoprotein (apo) E4 and Alzheimer\u2019s disease: Unique conformational and biophysical properties of apoE4 can modulate neuropathology. Acta Neurologica Scandinavica. Supplementum, l, 185, 8\u201314.","journal-title":"Acta Neurologica Scandinavica. Supplementum, l"},{"key":"8376_CR66","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-4-20","volume":"4","author":"P Marambaud","year":"2009","unstructured":"Marambaud, P., Dreses-Werringloer, U., & Vingtdeux, V. (2009). Calcium signaling in neurodegeneration. Molecular Neurodegeneration, 4, 20\u201324.","journal-title":"Molecular Neurodegeneration"},{"issue":"2","key":"8376_CR810","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.gene.2012.08.026","volume":"512","author":"TA Masoodi","year":"2013","unstructured":"Masoodi, T. A., Al Shammari, S. A., Al-Muammar, M. N., Alhamdan, A. A., & Talluri, V. R. (2013). Exploration of deleterious single nucleotide polymorphisms in late-onset Alzheimer disease susceptibility genes. Gene, 512(2), 429\u2013437.","journal-title":"Gene"},{"issue":"1\u20132","key":"8376_CR67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(00)00849-1","volume":"282","author":"KM Mattila","year":"2000","unstructured":"Mattila, K. M., Axelman, K., Rinne, J. O., Blomberg, M., Lehtim\u00e4ki, T., Laippala, P., et al. (2000). Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer\u2019s disease in women. Neuroscience Letters, 282(1\u20132), 45\u201348.","journal-title":"Neuroscience Letters"},{"issue":"1","key":"8376_CR68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2009.01.006","volume":"34","author":"FE McAlpine","year":"2009","unstructured":"McAlpine, F. E., Lee, J., Harms, A. S., Ruhn, K. A., Blurton-Jones, M., Hong, J., et al. (2009). Inhibition of soluble TNF signaling in a mouse model of Alzheimer\u2019s disease prevents pre-plaque amyloid-associated neuropathology. Neurobiology of Disease, 34(1), 163\u2013177.","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"8376_CR69","first-page":"18","volume":"1","author":"G Melesie","year":"2013","unstructured":"Melesie, G., & Dinsa, H. (2013). A literature review on: pathogenesis and management of dementia due to Alzheimer disease. Bio-Genetics Journal, 1(1), 18\u201331.","journal-title":"Bio-Genetics Journal"},{"issue":"4","key":"8376_CR850","doi-asserted-by":"crossref","first-page":"E566","DOI":"10.1002\/humu.20989","volume":"30","author":"RL Minster","year":"2009","unstructured":"Minster, R. L., Demirci, F. Y., Dekosky, S. T., & Kamboh, M. I. (2009). No association between CALHM1 variation and risk of Alzheimer disease. Human Mutation, 30(4), E566\u2013E569.","journal-title":"Human Mutation"},{"issue":"5","key":"8376_CR70","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj, A. C., Jun, G., Beecham, G. W., Wang, L. S., Vardarajan, B. N., Buros, J., et al. (2011). Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nature Genetics, 43(5), 436\u2013441.","journal-title":"Nature Genetics"},{"issue":"2","key":"8376_CR71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5507\/bp.2006.028","volume":"150","author":"Z Navratilova","year":"2006","unstructured":"Navratilova, Z. (2006). Polymorphisms in CCL2 & CCL5 chemokines\/chemokine receptors genes and their association with diseases. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc Czech Republic, 150(2), 191\u2013204.","journal-title":"Biomedical papers of the Medical Faculty of the University Palacky, Olomouc Czech Republic"},{"issue":"8","key":"8376_CR880","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/mds.10462","volume":"18","author":"M Nishimura","year":"2003","unstructured":"Nishimura, M., Kuno, S., Mizuta, I., Ohta, M., Maruyama, H., Kaji, R., et al. (2003). Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson\u2019s disease. Movement Disorders, 18(8), 953\u2013955.","journal-title":"Movement Disorders"},{"issue":"3","key":"8376_CR72","doi-asserted-by":"crossref","first-page":"e91242","DOI":"10.1371\/journal.pone.0091242","volume":"9","author":"I Parikh","year":"2014","unstructured":"Parikh, I., Fardo, D. W., & Estus, S. (2014). Genetics of PICALM expression and Alzheimer\u2019s disease. PLoS One, 9(3), e91242.","journal-title":"PLoS One"},{"issue":"3","key":"8376_CR73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3233\/JAD-2011-101791","volume":"24","author":"I Piaceri","year":"2011","unstructured":"Piaceri, I., Bagnoli, S., Lucenteforte, E., Mancuso, M., Tedde, A., & Siciliano, G. (2011). Implication of a genetic variant at PICALM in Alzheimer\u2019s disease patients and centenarians. Journal of Alzheimer\u2019s Disease, 24(3), 409\u2013413.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"6","key":"8376_CR74","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1468-1331.2006.01333.x","volume":"13","author":"E Porrello","year":"2006","unstructured":"Porrello, E., Monti, M. C., Sinforiani, E., Cairati, M., Guaita, A., Montomoli, C., et al. (2006). Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females. European Journal of Neurology, 13(6), 639\u2013644.","journal-title":"European Journal of Neurology"},{"issue":"1","key":"8376_CR75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11064-008-9626-8","volume":"34","author":"CN Randall","year":"2009","unstructured":"Randall, C. N., Strasburger, D., Prozonic, J., Morris, S. N., Winkie, A. D., Parker, G. R., et al. (2009). Cluster analysis of risk factor genetic polymorphisms in Alzheimer\u2019s disease. Neurochemical Research, 34(1), 23\u201328.","journal-title":"Neurochemical Research"},{"issue":"4","key":"8376_CR76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1357-4310(98)01229-5","volume":"4","author":"WJ Ray","year":"1998","unstructured":"Ray, W. J., Ashall, F., & Goate, A. M. (1998). Molecular pathogenesis of sporadic and familial forms of Alzheimer\u2019s disease. Molecular Medicine Today, 4(4), 151\u2013157.","journal-title":"Molecular Medicine Today"},{"issue":"3","key":"8376_CR77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","volume":"7","author":"C Reitz","year":"2011","unstructured":"Reitz, C., Brayne, C., & Mayeux, R. (2011). Epidemiology of Alzheimer disease. Nature Reviews Neurology, 7(3), 137\u2013152.","journal-title":"Nature Reviews Neurology"},{"key":"8376_CR78","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1523\/JNEUROSCI.1146-08.2008","volume":"22","author":"KL Richard","year":"2008","unstructured":"Richard, K. L., Filali, M., Pr\u00e9fontaine, P., & Rivest, S. (2008). Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1\u201342 and delay the cognitive decline in a mouse model of Alzheimer\u2019s disease. Journal of Neuroscience, 22, 5784\u20135793.","journal-title":"Journal of Neuroscience"},{"issue":"10","key":"8376_CR79","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/ng.2742","volume":"45","author":"S Ripke","year":"2013","unstructured":"Ripke, S., O\u2019Dushlaine, C., Chambert, K., Moran, J. L., K\u00e4hler, A. K., Akterin, S., et al. (2013). Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genetics, 45(10), 1150\u20131159.","journal-title":"Nature Genetics"},{"issue":"1","key":"8376_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/NMM:1:1:1","volume":"1","author":"K Sambamurti","year":"2002","unstructured":"Sambamurti, K., Greig, N. H., & Lahiri, D. K. (2002). Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer\u2019s disease. NeuroMolecular Medicine, 1(1), 1\u201331.","journal-title":"NeuroMolecular Medicine"},{"key":"8376_CR81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-8-9","volume":"8","author":"SB Sando","year":"2008","unstructured":"Sando, S. B., Melquist, S., Cannon, A., Hutton, L. M., Sletvold, O., Saltvedt, I., et al. (2008). APOE \u03b54 lowers age at onset and is a high risk factor for Alzheimer\u2019s disease; A case control study from central Norway. BMC Neurology, 8, 9.","journal-title":"BMC Neurology"},{"issue":"3","key":"8376_CR82","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-012-0996-2","volume":"124","author":"GD Schellenberg","year":"2012","unstructured":"Schellenberg, G. D., & Montine, T. J. (2012). The genetics and neuropathology of Alzheimer\u2019s disease. Acta Neuropathologica, 124(3), 305\u2013323.","journal-title":"Acta Neuropathologica"},{"issue":"18","key":"8376_CR83","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri, S., Fitzpatrick, A. L., Ikram, M. A., DeStefano, A. L., Gudnason, V., Boada, M., et al. (2010). Genome-wide analysis of genetic loci associated with Alzheimer disease. The Journal of American Medical Association, 303(18), 1832\u20131840.","journal-title":"The Journal of American Medical Association"},{"key":"8376_CR84","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2169\/internalmedicine.50.5119","volume":"21","author":"I Sezgin","year":"2011","unstructured":"Sezgin, I., Koksal, B., Bagci, G., Kurtulgan, H. K., & Ozdemir, O. (2011). CCR2 polymorphism in chronic renal failure patients requiring long-term hemodialysis. Internal Medicine, 21, 2457\u20132461.","journal-title":"Internal Medicine"},{"issue":"7","key":"8376_CR85","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/hmg\/5.7.985","volume":"5","author":"R Sherrington","year":"1996","unstructured":"Sherrington, R., Froelich, S., Sorbi, S., Chi, H., Rogaeva, E. A., Levesque, G., et al. (1996). Alzheimer\u2019s disease associated with mutations in presenilin 2 is rare and variably penetrant. Human Molecular Genetics, 5(7), 985\u2013988.","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"8376_CR151","first-page":"1849.e5-18","volume":"33","author":"H Shi","year":"2012","unstructured":"Shi, H., Belbin, O., Medway, C., Brown, K., Kalsheker, N., Carrasquillo, M., et al. (2012). Genetic variants influencing human aging from late-onset Alzheimer\u2019s disease (LOAD) genome-wide association studies (GWAS). Neurobiology of Aging, 33(8), 1849.e5-18.","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"8376_CR1040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2010-1380","volume":"20","author":"N Shibata","year":"2010","unstructured":"Shibata, N., Kuerban, B., Komatsu, M., Ohnuma, T., Baba, H., & Arai, H. (2010). Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer\u2019s disease in a Japanese population. Journal of Alzheimer\u2019s Disease, 20(2), 417\u2013421.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"2","key":"8376_CR86","first-page":"128","volume":"45","author":"M Shoji","year":"2005","unstructured":"Shoji, M., Kuwano, R., Asada, T., Imagawa, M., Higuchi, S., Urakami, K., et al. (2005). A proposal for diagnostic and clinical assessment criteria for Alzheimer\u2019s disease. Rinsh\u014d shinkeigaku, 45(2), 128\u2013137.","journal-title":"Rinsh\u014d shinkeigaku"},{"issue":"4","key":"8376_CR87","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/gme.0b013e3181df4a19","volume":"17","author":"EE Sundermann","year":"2010","unstructured":"Sundermann, E. E., Maki, P. M., & Bishop, J. R. (2010). A review of estrogen receptor \u03b1 gene (ESR1) polymorphisms, mood, and cognition. Menopause, 17(4), 874\u2013886.","journal-title":"Menopause"},{"issue":"3","key":"8376_CR1160","first-page":"546","volume":"32","author":"EK Tan","year":"2011","unstructured":"Tan, E. K., Ho, P., Cheng, S. Y., Yih, Y., Li, H. H., Fook-Chong, S., et al. (2011). CALHM1 variant is not associated with Alzheimer\u2019s disease among Asians. Neurobiology of Aging, 32(3), 546.","journal-title":"Neurobiology of Aging"},{"issue":"10","key":"8376_CR88","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2013.06.004","volume":"19","author":"MS Tan","year":"2013","unstructured":"Tan, M. S., Yu, J. T., & Tan, L. (2013). Bridging integrator 1 (BIN1): Form function, and Alzheimer\u2019s disease. Trends in Molecular Medicine, 19(10), 594\u2013603.","journal-title":"Trends in Molecular Medicine"},{"key":"8376_CR89","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1742-2094-9-106","volume":"9","author":"D Tweedie","year":"2012","unstructured":"Tweedie, D., Ferguson, R. A., Fishman, K., Frankola, K. A., Van Praag, H., Holloway, H. W., et al. (2012). Tumor necrosis factor-\u03b1 synthesis inhibitor 3, 6\u2032-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer\u2019s disease. Journal of Neuroinflammation, 9, 106\u2013108.","journal-title":"Journal of Neuroinflammation"},{"issue":"6","key":"8376_CR90","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjc.6600833","volume":"88","author":"IB Vande","year":"2003","unstructured":"Vande, I. B., Asosingh, K., Vanderkerken, K., Straetmans, N., Van Camp, B., & Van Riet, I. (2003). Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3. British Journal of Cancer, 88(6), 855\u2013862.","journal-title":"British Journal of Cancer"},{"issue":"3","key":"8376_CR91","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2010.12.008","volume":"489","author":"LZ Wang","year":"2011","unstructured":"Wang, L. Z., Tian, Y., Yu, J. T., Chen, W., Wu, Z. C., Zhang, Q., et al. (2011). Association between late-onset Alzheimer\u2019s disease and microsatellite polymorphisms in intron II of the human toll-like receptor 2 gene. Neuroscience Letters, 489(3), 164\u2013167.","journal-title":"Neuroscience Letters"},{"issue":"2","key":"8376_CR92","doi-asserted-by":"crossref","first-page":"e1001308","DOI":"10.1371\/journal.pgen.1001308","volume":"7","author":"EM Wijsman","year":"2011","unstructured":"Wijsman, E. M., Pankratz, N. D., Choi, Y., Rothstein, J. H., Faber, K. M., Cheng, R., et al. (2011). Genome-wide association of familial late-onset Alzheimer\u2019s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genetics, 7(2), e1001308.","journal-title":"PLoS Genetics"},{"issue":"2","key":"8376_CR93","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3233\/JAD-2010-101515","volume":"23","author":"RS Wilson","year":"2011","unstructured":"Wilson, R. S., Barral, S., Lee, J. H., Leurgans, S. E., Foroud, T. M., Sweet, R. A., et al. (2011). Heritability of different forms of memory in the Late Onset Alzheimer\u2019s Disease Family Study. Journal of Alzheimer\u2019s Disease, 23(2), 249\u2013255.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"4","key":"8376_CR94","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pneurobio.2010.04.005","volume":"91","author":"S Wuwongse","year":"2010","unstructured":"Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010). The putative neurodegenerative links between depression and Alzheimer\u2019s disease. Progress in Neurobiology, 91(4), 362\u2013375.","journal-title":"Progress in Neurobiology"},{"key":"8376_CR97","unstructured":"www.alzgene.org"},{"issue":"25","key":"8376_CR95","doi-asserted-by":"crossref","first-page":"21279","DOI":"10.1074\/jbc.M111.338376","volume":"287","author":"Q Xiao","year":"2012","unstructured":"Xiao, Q., Gil, S., Yan, P., Wang, Y., Han, S., Gonzales, E., et al. (2012). Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. Journal of Biological Chemistry, 287(25), 21279\u201321289.","journal-title":"Journal of Biological Chemistry"},{"key":"8376_CR96","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2013.09.006","volume":"111","author":"X Xing","year":"2013","unstructured":"Xing, X., Jia, J. P., Ji, X. J., & Tian, T. (2013). Estrogen associated gene polymorphisms and their interactions in the progress of Alzheimer\u2019s disease. Progress in Neurobiology, 111, 53\u201374.","journal-title":"Progress in Neurobiology"},{"issue":"19\u201320","key":"8376_CR98","first-page":"1516","volume":"411","author":"JT Yu","year":"2010","unstructured":"Yu, J. T., Li, L., Zhu, Q. X., Zhang, Q., Zhang, W., Wu, Z. C., et al. (2010). Implication of CLU gene polymorphisms in Chinese patients with Alzheimer\u2019s disease. Clinica Chimica Acta, 411(19\u201320), 1516\u20131519.","journal-title":"Clinica Chimica Acta"},{"key":"8376_CR99","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1742-2094-8-136","volume":"8","author":"JT Yu","year":"2011","unstructured":"Yu, J. T., Mou, S., Wang, L., Mao, C., & Tan, L. (2011). Toll-like receptor 2 \u2212196 to \u2212174 del polymorphism influences the susceptibility of Han Chinese people to Alzheimer\u2019 s disease. Journal of Neuroinflammation, 8, 136.","journal-title":"Journal of Neuroinflammation"},{"issue":"5","key":"8376_CR100","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1586\/erm.10.48","volume":"10","author":"T Zetzsche","year":"2010","unstructured":"Zetzsche, T., Rujescu, D., Hardy, J., & Hampel, H. (2010). Advances and perspectives from genetic research: Development of biological markers in Alzheimer\u2019s disease. Expert Review of Molecular Diagnostics, 10(5), 667\u2013690.","journal-title":"Expert Review of Molecular Diagnostics"},{"key":"8376_CR150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2010.06.018","volume":"1348","author":"Q Zhang","year":"2010","unstructured":"Zhang, Q., Yu, J. T., Zhu, Q. X., Zhang, W., Wu, Z. C., Miao, D., et al. (2010). Complement receptor 1 polymorphisms and risk of late-onset Alzheimer\u2019s disease. Brain Research, 1348, 216\u2013221.","journal-title":"Brain Research"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-015-8376-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-015-8376-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-015-8376-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T06:42:32Z","timestamp":1567320152000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-015-8376-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["8376"],"URL":"https:\/\/doi.org\/10.1007\/s12017-015-8376-4","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,9]]}}}